These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 9891831)

  • 1. [A randomized double-blind trial comparing cibenzoline and disopyramide in the prevention of recurrences of atrial tachyarrhythmia].
    Piot O; Flammang D; Dambrine P; Cheikel J; Jouannon C; Graux P; Baudouy Y; Bine-Scheck F; Leenhardt A
    Arch Mal Coeur Vaiss; 1998 Dec; 91(12):1481-6. PubMed ID: 9891831
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Cibenzoline versus propafenone by the oral route for preventing recurrence of atrial arrhythmia: multicenter, randomized, double-blind study].
    Lardoux H; Maison Blanche P; Marchand X; Canler A; Rouesnel P; Bleinc D; Péraudeau P; Scheck F
    Ann Cardiol Angeiol (Paris); 1996 Oct; 45(8):469-79. PubMed ID: 8952741
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Comparative study of cibenzoline and flecainide by oral route for preventing recurrence of paroxysmal atrial tachyarrhythmias].
    Maison-Blanche P; Brembilla-Perrot B; Fauchier JP; Babuty D; Garnier LF; Rouesnel P; Breuillac JC; Funck F; Scheck F; Peraudeau P; Medvedowsky JL
    Ann Cardiol Angeiol (Paris); 1997 Feb; 46(2):109-16. PubMed ID: 9137677
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Comparison of the efficacies of disopyramide, cibenzoline and aprindine for the termination of paroxysmal and persistent atrial fibrillation in elderly and non-elderly patients].
    Komatsu T; Nakamura S; Suzuki O; Yomogida K; Horiuchi D; Abe N; Kameda K; Owada S; Tomita H; Oikawa K; Okumura K
    J Cardiol; 2003 Apr; 41(4):191-8. PubMed ID: 12728540
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Long-term prevention of the recurrence of auricular fibrillation using cibenzoline. Multicenter study apropos of 89 case reports].
    Frances Y; Luccioni R; Delaage M; Donnarel G; Medvedowsky JL; Quiret JC
    Arch Mal Coeur Vaiss; 1985 Oct; 78 Spec No():99-103. PubMed ID: 3938266
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [A comparison between amiodarone and disopyramide in a delayed-release formulation in the prevention of recurrences of symptomatic atrial fibrillation].
    Villani R; Zoletti F; Veniani M; Locati F; Nava S
    Clin Ter; 1992 Jan; 140(1 Pt 2):35-9. PubMed ID: 1559321
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Study of the efficacy and tolerability of oral administration of cibenzoline in the prevention of recurrence of symptomatic atrial fibrillation].
    Medvedowsky JL; Bine-Scheck F; Dambrine P; Domerego JJ; Garnier LF; Labaki F; Piechaczyk P; Rouesnel P; Schenowitz A
    Ann Cardiol Angeiol (Paris); 1994 Feb; 43(2):89-96. PubMed ID: 8172484
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Relationship between duration of arrhythmia and subsequent preventive effect of disopyramide after cardioversion in patients with symptomatic paroxysmal and persistent atrial fibrillation].
    Komatsu T; Yomogida K; Nakamura S; Suzuki O; Horiuchi D; Kameda K; Tomita H; Abe N; Owada S; Oikawa K; Okumura K
    J Cardiol; 2003 Sep; 42(3):111-7. PubMed ID: 14526660
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cibenzoline for symptomatic ventricular arrhythmias: a prospective, randomized, double-blind, placebo controlled trial and a long term open label study.
    Lee MA; Fenster PE; Garcia ZM; Kipps JE; Huang SK
    Can J Cardiol; 1989 Sep; 5(6):295-8. PubMed ID: 2477130
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Value of cibenzoline in the preventive treatment of recurrent atrial arrhythmia].
    Pisapia A; Bine-Scheck F; Schenowitz A; Domerego JJ; Maraud L; Canler A; Labban N; Viart R; Aubry P; Beruben E
    Ann Cardiol Angeiol (Paris); 1994 Mar; 43(3):143-51. PubMed ID: 7912916
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Comparative study of the efficacy and tolerability of 2 modalities of intravenous cibenzoline administration in the reduction of recent spontaneous atrial arrhythmia].
    Hermida JS; Mabo P; Rouesnel P; Scheck F; Canler A; Barthélémy M; Wanszelbaum H
    Ann Cardiol Angeiol (Paris); 1995 Jan; 44(1):49-55. PubMed ID: 7702357
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Antiarrhythmic effect of disopyramide in ventricular extrasystole and auricular fibrillation].
    Breithardt G; Haerten K; Seipel L
    Z Kardiol; 1976 Aug; 65(8):713-23. PubMed ID: 61664
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Relationship between long-term preventive efficacy of cibenzoline and atrial natriuretic peptide in patients with paroxysmal atrial fibrillation].
    Komatsu T; Nakamura S; Kimura M; Owada S; Yomogida K; Kameda K; Oikawa K; Tomita H; Okumura K
    J Cardiol; 2002 Feb; 39(2):93-9. PubMed ID: 11873440
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Efficacy of cibenzoline in the termination and long-term prevention of paroxysmal atrial fibrillation: analysis based on the time of onset].
    Komatsu T; Nakamura S; Kimura M; Owada S; Saito E; Kobayashi T; Okumura K
    J Cardiol; 2001 Feb; 37(2):75-82. PubMed ID: 11255698
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Comparison of the efficacy/tolerability ratio of cibenzoline and propafenone in the treatment of ventricular arrhythmia].
    Babuty D; Cosnay P; Rouesnel P; Bine-Scheck F; Arnaud R; Fauchier JP
    Ann Cardiol Angeiol (Paris); 1992 Apr; 41(4):225-34. PubMed ID: 1642441
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cibenzoline versus flecainide in the prevention of paroxysmal atrial arrhythmias: a double-blind randomized study.
    Babuty D; D'Hautefeuille B; Scheck F; Mycinsky C; Pruvost P; Peraudeau P
    J Clin Pharmacol; 1995 May; 35(5):471-7. PubMed ID: 7657846
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Comparative effects of cibenzoline and hydroquinidine in the prevention of auricular fibrillation. A randomized double-blind study].
    Touboul P; Brembilla-Perrot B; Scheck F; Gabriel A; Lardoux H; Marchand X; Levy S
    Ann Cardiol Angeiol (Paris); 1995 Nov; 44(9):525-31. PubMed ID: 8745663
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Combination of oral administration of cibenzoline and digoxin in patients with supraventricular arrhythmia].
    Garnier LF; Bine-Scheck F; Pruvost P; Wanszelbaum H; Arnaud R
    Ann Cardiol Angeiol (Paris); 1992 Sep; 41(7):411-7. PubMed ID: 1285630
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Relationship between the therapeutic effects or side-effects and the serum disopyramide or mono-N-dealkylated disopyramide concentration after repeated oral administration of disopyramide to arrhythmic patients.
    Masuhara K; Ohno T; Hamaguchi K; Katoh K; Kashiwada K; Takahashi S; Tanaka Y; Someya K; Ogata H
    Int J Clin Pharmacol Res; 1995; 15(3):103-13. PubMed ID: 8847151
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Quantitative assessment of cibenzoline administration for vagally mediated paroxysmal atrial fibrillation using frequency-domain heart rate variability analysis.
    Miyakoshi M; Ikeda T; Miwa Y; Sakaki K; Ishiguro H; Abe A; Tsukada T; Mera H; Yusu S; Yoshino H
    J Cardiol; 2009 Aug; 54(1):86-92. PubMed ID: 19632526
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.